Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 451(1-2): 95-103, 2013 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-23651644

RESUMO

Osteoarthritis is characterized by slow degenerative processes in the articular cartilage within synovial joints. It could be interesting to develop a sustained-release formulation that could be effective on both pain/inflammation and restoration of mechanical integrity of the joint. Recently, an injectable system based on glycerol monooleate (GMO), containing clonidine as a model hydrophilic analgesic/anti-inflammatory drug and hyaluronic acid as a viscoelastic scaffold, showed promising potential as a biodegradable and biocompatible preparation to sustain the drug activity. However, drug release from the system is relatively fast (complete within 1 week) and the underlying drug release mechanisms not fully understood. The aims of this study were: (i) to significantly improve this type of local controlled drug delivery system by further sustaining clonidine release, and (ii) to elucidate the underlying mass transport mechanisms. The addition of FDA-approved inactive ingredients such as sodium oleate or purified soybean oil was found to be highly effective. The release rate could be substantially reduced (e.g., 50% release after 10 days), due to the increased hydrophobicity of the systems, resulting in slower and reduced water uptake and reduced drug mobility. Interestingly, Fick's second law of diffusion could be used to quantitatively describe drug release.


Assuntos
Clonidina/química , Sistemas de Liberação de Medicamentos , Glicerídeos/química , Ácido Hialurônico/química , Analgésicos/administração & dosagem , Analgésicos/química , Clonidina/administração & dosagem , Preparações de Ação Retardada , Composição de Medicamentos , Excipientes/química , Géis , Ácido Hialurônico/administração & dosagem , Interações Hidrofóbicas e Hidrofílicas , Injeções Intra-Articulares , Ácido Oleico/química , Osteoartrite/tratamento farmacológico , Óleo de Soja/química , Fatores de Tempo , Viscossuplementos/administração & dosagem , Viscossuplementos/química
2.
Drug Deliv ; 16(2): 82-91, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19267299

RESUMO

The effects of chemical enhancers and sonophoresis on the transdermal permeation of tizanidine hydrochloride (TIZ) across mouse skin were investigated. Parameters including drug solubility, apparent partition coefficient (APC), drug permeation, and degradation in skin were determined. Low frequency ultrasound was also applied in the presence and absence of chemical enhancers to assess whether drug permeation improved. APC values indicated that TIZ preferentially partitions into intercellular spaces and does not form a reservoir, with the drug also exhibiting good enzymatic stability in skin. Most of the enhancers studied significantly increased the permeation rate of TIZ through full thickness mouse skin in comparison with TIZ formulated in phosphate buffer. Maximum enhancement was observed for TIZ formulated as a suspension in 50% v/v aqueous ethanol containing 5% v/v citral. Sonophoresis significantly (p < 0.05) increased the cumulative amount of TIZ permeating through the skin at 15 and 30 min in comparison to passive diffusion. A synergistic effect was noted when sonophoresis was applied in the presence of chemical enhancers. The results suggest that the formulation of TIZ with an appropriate penetration enhancer may be useful in the development of a therapeutic system to deliver TIZ across the skin for a prolonged period, i.e. 24 hr. The application of ultrasound in association with chemical enhancers, such as the combination of 5% v/v citral in 50% v/v aqueous ethanol, could further serve as a non-oral and non-invasive drug delivery modality for the immediate therapeutic effect of muscle relaxants such as TIZ.


Assuntos
Adjuvantes Farmacêuticos/farmacologia , Clonidina/análogos & derivados , Absorção Cutânea/efeitos dos fármacos , Absorção Cutânea/efeitos da radiação , Ultrassom , 1-Octanol/química , Monoterpenos Acíclicos , Administração Cutânea , Animais , Soluções Tampão , Clonidina/administração & dosagem , Clonidina/química , Clonidina/metabolismo , Cicloexanóis/farmacologia , Cicloexenos/farmacologia , Etanol/química , Etanol/farmacologia , Eucaliptol , Técnicas In Vitro , Limoneno , Camundongos , Óleo Mineral/química , Monoterpenos/farmacologia , Miristatos/química , Miristatos/farmacocinética , Ácido Oleico/farmacologia , Pele/efeitos dos fármacos , Pele/metabolismo , Solubilidade , Terpenos/farmacologia
4.
Drug Dev Ind Pharm ; 25(3): 373-7, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10071833

RESUMO

The effects of Tween 80 (polysorbate 80) and Span 80 (sorbitan monooleate) surfactants on release characteristics of clonidine hydrochloride from ethylcellulose 10 and 20 cps matrix films containing castor oil as a plasticizer were investigated. The release rates of drug from these films in water at 37 degrees C were found to increase with the addition of surfactant, which was highest for the film prepared from ethylcellulose 20 cps with Tween 80. The experimental values of the cumulative amount of drug released were found to conform to the solution matrix model. The calculated values of the cumulative amount of clonidine hydrochloride released using the experimentally determined diffusion coefficients were also found to be in good agreement with the observed values.


Assuntos
Clonidina/química , Algoritmos , Óleo de Rícino , Celulose/análogos & derivados , Clonidina/administração & dosagem , Difusão , Portadores de Fármacos , Hexoses , Excipientes Farmacêuticos , Polissorbatos , Solubilidade , Soluções , Tensoativos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA